Clinical outcome of pelvic exenteration in patients with advanced or recurrent uterine cervical cancer

By Tanaka Sota   Nagase Satoru   Kaiho-Sakuma Michiko   Nagai Tomoyuki   Kurosawa Hiroki   Toyoshima Masafumi   Tokunaga Hideki   Otsuki Takeo   Utsunomiya Hiroki   Takano Tadao   Niikura Hitoshi   Ito Kiyoshi   Yaegashi Nobuo  

International Journal of Clinical Oncology, Vol. 19, Iss. 1, 2014-02 ,pp. : 133-138

Springer Publishing Company

Access to resources Recommend Favorite

A CD44⁻/CD24⁺ phenotype is a poor prognostic marker in early invasive breast cancer

By Ahmed Mohamed   Aleskandarany Mohammed   Rakha Emad   Moustafa Radwa   Benhasouna Ahmed   Nolan Christopher   Green Andrew   Ilyas Mohammad   Ellis Ian  

Breast Cancer Research and Treatment, Vol. 133, Iss. 3, 2012-06 ,pp. : 979-995

Springer Publishing Company

Access to resources Recommend Favorite

The Expression Patterns of Standard and Variant CD44 Molecules in Normal Uterine Cervix and Cervical Cancer

By Shimabukuro K.   Toyamo-Sorimachi N.   Ozaki Y.   Goi T.   Furukawa K.   Miyasaka M.   Aso T.  

Gynecologic Oncology, Vol. 64, Iss. 1, 1997-01 ,pp. : 26-34

Elsevier

Access to resources Recommend Favorite

Multiple Tumour Marker Assays in Advanced Cervical Cancer: Relationship to Chemotherapy Response and Clinical Outcome

By Scambia G.   Panici P.B.   Foti E.   Ferrandina G.   Leone F.P.G.   Marciano M.   Mancuso S.  

European Journal of Cancer, Vol. 32, Iss. 2, 1996-02 ,pp. : 259-263

Elsevier

Access to resources Recommend Favorite

Expression and Mutation of H-ras in Uterine Cervical Cancer

By Lee J.H.   Lee S.K.   Yang M.H.   Ahmed M.M.   Mohiuddin M.   Lee E.Y.  

Gynecologic Oncology, Vol. 62, Iss. 1, 1996-07 ,pp. : 49-54

Academic Press

Access to resources Recommend Favorite